Stay updated on MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page.

Latest updates to the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page
- Check4 days agoChange Detected- The page now shows Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.1%

- Check11 days agoChange DetectedThe page now displays a glossary and updates metadata labels to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', with minor wording changes such as 'No FEAR Act Data'.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; no study content or functionality were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedLocations were reorganized under a single Locations section, consolidating state entries (Colorado, Illinois, Maryland, Massachusetts, New York, Texas, Utah) and updating the page revision from v3.3.2 to v3.3.3. The HHS Vulnerability Disclosure link was removed.SummaryDifference0.9%

- Check75 days agoChange DetectedPublications section now notes that PubMed entries are auto-filled and may not all relate to the study; revision numbers updated to v3.3.2 and v3.2.0.SummaryDifference0.1%

- Check83 days agoChange DetectedThe notice about government funding lapse and NIH Clinical Center operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page.